Mitotane will minimize the extent or effect of abemaciclib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Coadministration of abemaciclib with sturdy CYP3A4 inducers reduces plasma focus of abemaciclib and its metabolites. dabrafenib will reduce the extent or influence of abemaciclib by impacting hepatic/intestinal enzyme https://harryw221nyj5.blogtov.com/profile